Brian V Elliott B Comm, senior expert
Brian is a very experienced manager having spent over 35 years in Senior Management positions in the pharmaceutical industry and the health related public sectors. Following 10 years service with the Irish Government Industrial Development Authority in Ireland, France and Lesotho, Brian entered the pharmaceutical industry where he held positions as International Sales Director with Norton Healthcare Generics, based in Ireland and the UK. He assumed the position of Director of Janssen China,and subsequently was appointed International Trade Director, Janssen Africa, Middle East, West Asia.
He was recruited by Tibotec-Virco NV, a Belgian biotech company as Senior Vice President, Corporate Alliances and Business Development and was also the CEO of Tibotec Virco, Ireland.
He established Axios International Consultants Ltd in Ireland, and was Chairman of the organization for 5 years during which he undertook many developing country health related projects including:
- UNAIDS negotiator with pharma industry on acces to antiretrovirals, where he co-designed the UNAIDS Drug Access Initiative and established pilot projects in Vietnam, Chile, Uganda and Cote d’Ivoire.
- Advisor to the Danish Government Overseas Aid Ministry on International HIV/AIDS policy.
- The design and implementation of several global access initiatives including:
- BMS - Secure the Future project in South Africa, BMS
- Abbott - Step Forward for Children project in Tanzania and Burkina Faso, Abbott
- Gilead - Global Viread donation programme
- Pfizer - diflucan donation project Pfizer
In 2008 he was appointed Executive Director of The Medical Transparency Alliance MeTA. An alliance of DFID, World Bank, WHO aimed at increasing access to essential medicines in 7 pilot countries, Peru, Jordan, Kyrgizstan, Uganda, Zambia, Ghana and The Philippines, and also became a member of AMfM Expert Advisory Panel on review of the project evaluation process.
Recently he has advised a number of pharmaceutical companies on the establishment of Global Access Programs.